(Q45475260)

English

The N137 and P140 amino acids in the p51 and the P95 amino acid in the p66 subunit of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase are instrumental to maintain catalytic activity and to design new classes of anti-HIV-1 drugs

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

The N137 and P140 amino acids in the p51 and the P95 amino acid in the p66 subunit of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase are instrumental to maintain catalytic activity and to design new classes of anti-HIV-1 drugs (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Sonsoles Velázquez

5

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

María-José Camarasa

8

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Francesca Ceccherini-Silberstein

6

object named as

Francesca Ceccherini-Silberstein

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Sonia de Castro

object named as

Sonia de Castro

4

0 references

object named as

Erik De Clercq

7

0 references

object named as

Federico Gago

10

0 references

11

object named as

Jan Balzarini

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Fátima Rodríguez-Barrios

3

object named as

Fátima Rodríguez-Barrios

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

1

object named as

Joeri Auwerx

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Carlo Federico Perno

9

object named as

Carlo-Federico Perno

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

author name string

Joke Van Nieuwenhove

2

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

language of work or name

0 references

publication date

1 April 2005

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

579

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

2294-2300

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Antiviral drugs in current clinical use.

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.02.077

21 January 2018

Current status of the non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.02.077

21 January 2018

Mutational analysis of Tyr-318 within the non-nucleoside reverse transcriptase inhibitor binding pocket of human immunodeficiency virus type I reverse transcriptase

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.02.077

21 January 2018

Role of residues in the tryptophan repeat motif for HIV-1 reverse transcriptase dimerization

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.02.077

21 January 2018

The beta7-beta8 loop of the p51 subunit in the heterodimeric (p66/p51) human immunodeficiency virus type 1 reverse transcriptase is essential for the catalytic function of the p66 subunit

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.02.077

21 January 2018

Functional characterization of chimeric reverse transcriptases with polypeptide subunits of highly divergent HIV-1 group M and O strains.

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.02.077

21 January 2018

TSAO analogues. Stereospecific synthesis and anti-HIV-1 activity of 1-[2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3'-spiro -5''- (4''-amino-1'',2''-oxathiole 2'',2''-dioxide) pyrimidine and pyrimidine-modified nucleosides

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.02.077

21 January 2018

A two plasmid co-expression system in Escherichia coli for the production of virion-like reverse transcriptase of the human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.02.077

21 January 2018

Susceptibility of feline immunodeficiency virus/human immunodeficiency virus type 1 reverse transcriptase chimeras to non-nucleoside RT inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.02.077

21 January 2018

Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.02.077

21 January 2018

Identification of a putative binding site for [2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)thymine (TSAO) derivatives at the p51-p66 interface of HIV-1 reverse transcriptase.

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.02.077

21 January 2018

Nonnucleoside reverse transcriptase inhibitors are chemical enhancers of dimerization of the HIV type 1 reverse transcriptase

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.02.077

21 January 2018

Modulation of the oligomeric structures of HIV-1 retroviral enzymes by synthetic peptides and small molecules

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.02.077

21 January 2018

The p51 subunit of human immunodeficiency virus type 1 reverse transcriptase is essential in loading the p66 subunit on the template primer

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.02.077

21 January 2018

Human immunodeficiency virus type 1 reverse transcriptase dimer destabilization by 1-[Spiro[4"-amino-2",2" -dioxo-1",2" -oxathiole-5",3'-[2', 5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]]]-3-ethylthy mine

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.02.077

21 January 2018

Destabilization of the HIV-1 reverse transcriptase dimer upon interaction with N-acyl hydrazone inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.02.077

21 January 2018

A novel mutation (F227L) arises in the reverse transcriptase of human immunodeficiency virus type 1 on dose-escalating treatment of HIV type 1-infected cell cultures with the nonnucleoside reverse transcriptase inhibitor thiocarboxanilide UC-781.

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.02.077

21 January 2018

Crystal structures of HIV-1 reverse transcriptases mutated at codons 100, 106 and 108 and mechanisms of resistance to non-nucleoside inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.02.077

21 January 2018

Identifiers

10.1016/J.FEBSLET.2005.02.077

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45475260&oldid=2076974642"